Table 4.
Response to LDFRT, carboplatin, and paclitaxel at primary and nodal sites, presented as frequency (percent)
| Response | N | CR | PR | SD | PD | RR |
|---|---|---|---|---|---|---|
| Primary site | 24 | 15 (62.5) | 8 (33.3) | 1 (4.2) | - | 23 (95.8) |
| Nodal | 19 | 9 (47.4) | 7 (36.8) | 3 (15.8) | - | 16 (84.2) |
| Overall | 24 | 9 (37.5) | 13 (54.2) | 2 (8.3) | - | 22 (91.7) |
Response rates at primary site, nodes, and overall. Note that only 19 patients had nodal disease.
CR, complete response; LDFRT, low-dose fractionated radiation therapy; PD, progressive disease; PR, partial response; RR, response rate; SD, stable disease.